XML 16 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flow (Unaudited) - USD ($)
9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net (Loss) $ (10,150,082) $ (3,973,806)
Adjustments to reconcile Net (Loss) to Net Cash provided by operations:    
Depreciation and amortization 2,957,337 329,478
Debt discount amortization 24,144 11,505
Stock grants 548,058 496,143
Stock for services 272,000 22,350
Employee stock awards 688,750 644,724
Gain on bargain purchase (1,599,161)
Changes in Current Assets and Liabilities    
Accounts receivable 91,995 611,740
Allowance for doubtful accounts (124,313) (9,000)
Due to (from) related parties 2,858 (11,354)
Inventories (250,383) (1,546,301)
Prepaid expenses 301,241 38,213
Deposits (93,830) (39,115)
Accounts payable 2,357,708 (113,389)
Accrued liabilities 271,063 (66,413)
Net cash used in operating activities (3,103,454) (5,204,386)
Cash flows from investing activities    
Purchase of equipment (356,022) (1,629,833)
Acquisition Deposit (250,000)
Net cash used in investing activities (356,022) (1,879,833)
Cash flow from financing activities    
Note payable related party 415,000
Note payment - related party (1,500,000)
Insurance premium note payment (322,209) (99,907)
Contingent consideration payment (300,000) (50,000)
Convertible promissory note 1,534,000
Sale of common stock 2,465,540 3,591,030
Purchase of common stock (124,000)
Factoring liability 936,750
Common stock issued for exercised warrants 4,767,625
Organizational and fundraising costs (285,981) (872,870)
Net cash provided by financing activities 1,409,100 8,745,878
Net increase in cash (2,050,376) 1,661,659
Cash, beginning of period 2,181,246 4,381,643
Cash, end of period 130,870 6,043,302
Supplemental cash flow disclosures    
Cash paid during the period for - Interest 346,800 11,979
Cash paid during the period for - Income taxes
Non-cash investing and financing activities:    
Additional paid-in-capital (11)
Common stock 11
Issuance of common stock 4,624,005
Contingent consideration payable 1,250,000
Patent acquisition (5,874,005)
Convertible promissory note and accrued interest (318,226)
Convertible promissory note conversion 318,226
Insurance premium note payment 165,120
Prepaid expenses (165,120)
Right of use assets - operating leases (4,168,771)  
Operating lease liability 4,168,771  
Other Intangible Assets 2,312,609
Note payable related party (2,596,200)
Deposits (109,250)
Equipment 392,841
Total non-cash investing and financing activities